Genetic score advances personalized treatment strategies with promising AML drug
UF Health researchers have developed a genetic score to predict patient outcomes with a promising targeted drug treatment.
Posted in
Cancer Research News
Research Snapshot: Noninvasive blood testing method shows promise in evaluating liver cancer
The preliminary findings indicate that the technique could allow physicians to assess patients’ tumor burden without invasive tumor biopsies.
Research Snapshot: UF researchers use 3D models to evaluate immunotherapy treatment in glioblastoma and osteosarcoma
Researchers developed a new method to evaluate how immunotherapy treatment kills tumor cells.
Study assesses change over time of anxiety, depression in brain tumor patients
Researchers identify factors that may predict anxiety/depression symptom trajectories in brain tumor patients.
Telehealth financial counseling intervention may ease burden for cancer patients
UF Health Cancer Center researchers created an intervention that connected UF Health cancer patients with telehealth financial counseling.
Using patients’ genetic profile to inform AML treatment could help reduce racial disparities
A multi-gene metric known as ACS10 revealed a close link between genetic factors and racial disparities in pediatric AML outcomes.
UF Health researchers use AI to improve brain tumor analysis
UF Health researchers have deployed AI to refine and accelerate the evaluation of a common type of brain tumor.
Scientists discover key to a potential natural cancer treatment’s potency
The discovery offers potentially easier ways to study and manufacture complex natural chemicals, including those that could become medicines.
Research Snapshot: UF researchers discover new role of RNA modification in lung cancer cell growth
The study suggests that erasing an abundant modification on certain types of RNA may be a way to therapeutically target lung cancer.
UF Health Cancer Center expands research programs to enhance discoveries
The UF Health Cancer Center has expanded its research programs to strengthen the impact of cancer research and facilitate clinical translation of discoveries.
